IP Library Granted Patent US 8,414,761
Granted Patent B2
US 8,414,761 · App. 13/226,185 · Granted Apr 9, 2013

Biosensor

Inventors: Masao Gotoh (Sagamihara, JP); Hiroki Mure (Fujisawa, JP); Hiroshi Shirakawa (Fujisawa, JP)
Assignee: Abbott Diabetes Care Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,414,761
App. No.
13/226,185
Granted
Apr 9, 2013
Kind
B2
Abstract

A biosensor comprises a space part for sucking and housing a sample formed of two upper and lower plates, the two plates being stuck together by an adhesive layer, the space part for sucking and housing the sample being constituted so as to be partially opened in the peripheral part and partially closed by the adhesive layer, and has a working electrode having at least glucose oxidase immobilized thereon and a counter electrode on the same plane of the plate.

Claims (62)

1. A biosensor for determining a concentration of glucose in a sample, the biosensor comprising:

a first substrate and a second substrate disposed over the first substrate, wherein the first and second substrates define a sensor comprising a proximal end and a distal end, the distal end being configured for insertion into a sensor reader, wherein the proximal end comprises a narrow portion as compared to the distal end, and wherein the first substrate comprises a length extending from the proximal end to the distal end and the second substrate comprises a length extending from the proximal end to the distal end, wherein the length of the second substrate is greater than the length of the first substrate;

a spacer layer disposed between the first and second substrates and defining an aperture along a first side edge of the sensor configured to receive a sample fluid;

a working electrode disposed on the narrow portion of the proximal end of the first substrate and extending to the distal end of the first substrate;

a mediator and a glucose dehydrogenase disposed on the working electrode; and

a counter/reference electrode disposed on the narrow portion of the proximal end of the second substrate and extending to the distal end of the second substrate.

2. The biosensor of claim 1 , wherein the spacer layer comprises a length extending from the proximal end to the distal end, wherein the length of the spacer layer is shorter than the length of the first substrate and the length of the second substrate.

3. The biosensor of claim 1 , wherein the first substrate, second substrate and spacer layer define a space for housing a sample, the space for housing a sample being in communication with the aperture and having a volume that is no more than 1.0 μL.

4. The biosensor of claim 3 , wherein the space for housing a sample has a volume that is no more than 0.5 μL.

5. The biosensor of claim 1 , wherein the spacer layer defines an aperture along a second side edge of the biosensor configured to receive a sample fluid.

6. The biosensor of claim 5 , wherein the aperture along the first side edge is in communication with the aperture along the second side edge.

7. The biosensor of claim 1 , wherein the working electrode is constructed of a palladium material.

8. The biosensor of claim 1 , wherein the counter/reference electrode is constructed of a gold material.

9. The biosensor of claim 1 , wherein the mediator is potassium ferricyanide or parabenzoquinone.

10. A method of determining a concentration of glucose in a subject, the method comprising:

contacting body fluid of the subject with a biosensor to generate an electrical signal, the biosensor comprising:

a first substrate and a second substrate disposed over the first substrate, wherein the first and second substrates define a sensor comprising a proximal end and a distal end, the distal end being configured for insertion into a sensor reader, wherein the proximal end comprises a narrow portion as compared to the distal end, and wherein the first substrate comprises a length extending from the proximal end to the distal end and the second substrate comprises a length extending from the proximal end to the distal end, wherein the length of the second substrate is greater than the length of the first substrate;

a spacer layer disposed between the first and second substrates and defining an aperture along a first side edge of the sensor configured to receive a sample fluid;

a working electrode disposed on the narrow portion of the proximal end of the first substrate and extending to the distal end of the first substrate;

a mediator and a glucose dehydrogenase disposed on the working electrode; and

a counter/reference electrode disposed on the narrow portion of the proximal end of the second substrate and extending to the distal end of the second substrate; and

determining the concentration of glucose in the body fluid using the generated electrical signal.

11. The method of claim 10 , wherein determining the concentration of glucose comprises determining the concentration of glucose by amperometry using the generated electrical signal.

12. The method of claim 10 , wherein the spacer layer comprises a length extending from the proximal end to the distal end, wherein the length of the spacer layer is shorter than the length of the first substrate and the length of the second substrate.

13. The method of claim 10 , wherein the first substrate, second substrate and spacer layer define a space for housing a sample, the space for housing a sample being in communication with the aperture and having a volume that is no more than 1.0 μL.

14. The method of claim 13 , wherein the space for housing a sample has a volume that is no more than 0.5 μL.

15. The method of claim 10 , wherein the spacer layer defines an aperture along a second side edge of the biosensor configured to receive a sample fluid.

16. The method of claim 15 , wherein the aperture along the first side edge is in communication with the aperture along the second side edge.

17. The method of claim 10 , wherein the working electrode is constructed of a palladium material.

18. The method of claim 10 , wherein the counter/reference electrode is constructed of a gold material.

19. The method of claim 10 , wherein the mediator is potassium ferricyanide or parabenzoquinone.

20. A biosensor device comprising:

a device body having a connector part and a control part, the connector part having input terminals;

a biosensor comprising:

a first substrate and a second substrate disposed over the first substrate, wherein the first and second substrates define a sensor comprising a proximal end and a distal end, the distal end being configured for insertion into a sensor reader, wherein the proximal end comprises a narrow portion as compared to the distal end, and wherein the first substrate comprises a length extending from the proximal end to the distal end and the second substrate comprises a length extending from the proximal end to the distal end, wherein the length of the second substrate is greater than the length of the first substrate;

a spacer layer disposed between the first and second substrates and defining an aperture along a first side edge of the sensor configured to receive a sample fluid;

a working electrode disposed on the narrow portion of the proximal end of the first substrate and extending to the distal end of the first substrate;

a mediator and a glucose dehydrogenase disposed on the working electrode; and

a counter/reference electrode disposed on the narrow portion of the proximal end of the second substrate and extending to the distal end of the second substrate,

wherein the input terminals of the connector part are electrically connected to the working electrode when the biosensor is inserted into the connector part of the device body.

21. The biosensor device of claim 20 , wherein the spacer layer comprises a length extending from the proximal end to the distal end, wherein the length of the spacer layer is shorter than the length of the first substrate and the length of the second substrate.

22. The biosensor device of claim 20 , wherein the first substrate, second substrate and spacer layer define a space for housing a sample, the space for housing a sample being in communication with the aperture and having a volume that is no more than 1.0 μL.

23. The biosensor device of claim 22 , wherein the space for housing a sample has a volume that is no more than 0.5 μL.

24. The biosensor device of claim 20 , wherein the spacer layer defines an aperture along a second side edge of the biosensor configured to receive a sample fluid.

25. The biosensor device of claim 24 , wherein the aperture along the first side edge is in communication with the aperture along the second side edge.

26. The biosensor device of claim 20 , wherein the working electrode is constructed of a palladium material.

27. The biosensor device of claim 20 , wherein the counter/reference electrode is constructed of a gold material.

28. The biosensor device of claim 20 , wherein the mediator is potassium ferricyanide or parabenzoquinone.

29. A biosensor comprising:

an insulating material having a first surface and a second surface;

a first portion of an electrode disposed on the first surface of the insulating material;

a second portion of the electrode disposed on the second surface of the insulating material,

a through-hole located in the insulating material and in contact with the first portion of the electrode on the first surface of the insulating material and the second portion of the electrode on the second surface of the insulating material;

wherein the through-hole is filled with a conductive material thereby providing electrical communication between the first portion of the electrode on the first surface of the insulating material and the second portion of the electrode on the second surface of the insulating material.

30. The biosensor of claim 29 , wherein the through-hole is filled with carbon paste.

31. The biosensor of claim 29 , further comprising a second electrode.

32. The biosensor of claim 29 , wherein the electrode is a counter electrode.

33. The biosensor of claim 32 , wherein the counter electrode comprises platinum, gold, carbon, or palladium.

34. The biosensor of claim 29 , wherein the electrode is a working electrode.

35. The biosensor of claim 34 , wherein the working electrode comprises platinum, gold, carbon, or palladium.

36. The biosensor of claim 34 , wherein the working electrode comprises an analyte-responsive enzyme selected from the group consisting of glucose oxidase or glucose dehydrogenase.

37. The biosensor of claim 29 , wherein the biosensor comprises a proximal end and a distal end, the distal end being configured for attachment to a device that measures the analyte, wherein the proximal end comprises a narrow portion as compared to the distal end.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 23, 2011
From: NOK CORPORATION
To: THERASENSE, INC.
Reel/Frame 026964/0282 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 23, 2011
From: GOTOH, MASAO; MURE, HIROKI; SHIRAKAWA, HIROSHI
To: NOK CORPORATION
Reel/Frame 026964/0924 →
CHANGE OF NAME Recorded Sep 23, 2011
From: THERASENSE, INC.
To: ABBOTT DIABETES CARE INC.
Reel/Frame 026971/0101 →
Priority Claims (4)
JP 9-267812 · Sep 12, 1997 · national
JP 9-267814 · Sep 12, 1997 · national
JP 9-282642 · Sep 30, 1997 · national
JP 9-282643 · Sep 30, 1997 · national
Continuity (8)
Continuation 13181208 · Jul 12, 2011
Continuation 12068014 · Jan 31, 2008
Continuation 11123230 · May 6, 2005
Continuation 10303084 · Nov 25, 2002
Continuation 09664319 · Sep 18, 2000
Division 09484539 · Jan 18, 2000
Continuation 08990997 · Dec 15, 1997
Related Publication 20120055812A1 · Mar 8, 2012